2021年7月29日 · Ryeqo is a medicine used in women of reproductive age to treat: moderate to severe symptoms of uterine fibroids (non-cancerous growths in the womb); symptoms of endometriosis (a condition in which tissue similar to the lining of …

自 2021 年 9 月起， GnRH 拮抗剂 Ryeqo （Relugolix）作为一种全新的口服治疗选择，用于治疗中度至重度 子宫肌瘤 症状，已在德国上市。 子宫肌瘤是一种发生在子宫肌层的良性肿瘤疾病，约有 70% 的 45 岁以上女性受其影响。 尽管多数情况下无症状，但它们往往会引发周期性疼痛，甚至可能非常严重。 这主要是由于肌瘤的快速生长以及有时可达较大的体积。 子宫肌瘤的治疗. 治疗包括手术干预或通过药物降低雌激素和孕激素的血清水平以抑制肌瘤生长的方法。 例如，可 …

Ryeqo是一款复方片，其活性药物成分中： relugolix是一种促性腺激素释放激素（GnRH）受体拮抗剂，可减少卵巢产生的雌激素（和其他激素）水平，缓解 ...

Ryeqo contains the active substances relugolix, estradiol and norethisterone acetate. It is used to treat moderate to severe symptoms of uterine fibroids (commonly known as myomas), which are non-cancerous tumours of the uterus (womb). Ryeqo is used in adult women (over 18 years of age) before they reach menopause.

Ryeqo is a medicine used in women of reproductive age to treat: • moderate to severe symptoms of uterine fibroids (non -cancerous growths in the womb); • symptoms of endometriosis (a condition in which tissue similar to the lining of the womb grows

Relugolix with estradiol and norethisterone acetate tablets (Ryeqo®) for the treatment of moderate to severe symptoms of uterine fibroids in adult women of reproductive age (June 2022)

Ryeqo treatment should be initiated and supervised by a physician experienced in the diagnosis and treatment of uterine fibroids and/or endometriosis. Posology . One tablet of Ryeqo must be taken once daily, at about the same time with or without food. Tablets should be taken with some liquid as needed (see section 5.2). BMD loss and osteoporosis

Ryeqo is indicated in adult women of reproductive age for: 1. Treatment of moderate to severe symptoms of uterine fibroids; Symptomatic treatment of endometriosis in women with a history of previous medical or surgical treatment for their endometriosis

2023年4月5日 · Ryeqo is taken to treat adult women (over the age of 18 years) before they reach menopause for moderate to severe symptoms of uterine fibroids (commonly known as myomas), and for symptomatic treatment of endometriosis in women with a history of previous medical or surgical treatment for their endometriosis. For more information, see Section 1.

Ryeqo is used for the treatment of endometriosis to decrease the symptoms due to displaced tissue of the lining of the womb. This medicine contains relugolix, which blocks certain receptors in the brain and this reduces the